Since August 2021, Moderna’s stock has been in a downtrend.
The latest decline started in May 2024 and ended in April 2025, dropping from 170 to 23.
Since April 2025, a corrective move has begun for one of the sub-waves.
This move is nearly complete, with final targets at 36 -> 38.
This does not mean the uptrend is over - after some time and additional corrections, we should see a move toward 57.
The longer-term outlook remains clear and largely positive.
For now, let's focus on the targets mentioned. Further developments will be shared in new ideas.
---
Please subscribe and leave a comment.
You’ll get new information faster than anyone else.
---
The latest decline started in May 2024 and ended in April 2025, dropping from 170 to 23.
Since April 2025, a corrective move has begun for one of the sub-waves.
This move is nearly complete, with final targets at 36 -> 38.
This does not mean the uptrend is over - after some time and additional corrections, we should see a move toward 57.
The longer-term outlook remains clear and largely positive.
For now, let's focus on the targets mentioned. Further developments will be shared in new ideas.
---
Please subscribe and leave a comment.
You’ll get new information faster than anyone else.
---
거래청산: 타겟 닿음
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.